Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: monotherapy or combination therapy?
…, A Türkmen, A Ersoy, M Ersöz, A Gücüyener - Indian journal of medical …, 2012 - Elsevier
… used as either monotherapy or combination therapy. … infected with colistin-only-susceptible
(COS) A. baumannii and treated with either colistin monotherapy or colistin combined therapy…
(COS) A. baumannii and treated with either colistin monotherapy or colistin combined therapy…
Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis
J Wang, H Niu, R Wang, Y Cai - International journal of antimicrobial agents, 2019 - Elsevier
… colistin monotherapy and combination therapy. However, … studies on colistin monotherapy
or combination therapy have … colistin alone or in combination for the treatment A. baumannii …
or combination therapy have … colistin alone or in combination for the treatment A. baumannii …
[HTML][HTML] Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A …
C Huang, I Chen, T Tang - Journal of clinical medicine, 2022 - mdpi.com
… with other antibiotics is a way to enhance colistin activity. The purpose of this meta-analysis …
of treatment with colistin monotherapy versus colistin plus meropenem combination therapy …
of treatment with colistin monotherapy versus colistin plus meropenem combination therapy …
Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
KZ Vardakas, AD Mavroudis, M Georgiou… - International journal of …, 2018 - Elsevier
… other than IV were used (eg oral, topical solutions, intraventicular or intrathecal, intramuscular,
inhaled), or the comparator group in combination therapy did not receive colistin. No …
inhaled), or the comparator group in combination therapy did not receive colistin. No …
[HTML][HTML] Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
Z Chen, Y Chen, Y Fang, X Wang, Y Chen, Q Qi… - Scientific reports, 2015 - nature.com
… The aim of this study was to assess the safety and efficacy of colistin monotherapy vs. other
… not differ significantly between colistin-based combination therapy and monotherapy (OR = …
… not differ significantly between colistin-based combination therapy and monotherapy (OR = …
[HTML][HTML] … -dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A …
J Liu, Y Shu, F Zhu, B Feng, Z Zhang, L Liu… - Journal of Global …, 2021 - Elsevier
… colistin … treatment with colistin with rifampicin or colistin with fosfomycin was associated with
a significantly higher rate of microbiological eradication compared with colistin monotherapy (…
a significantly higher rate of microbiological eradication compared with colistin monotherapy (…
Rifampicin as Adjunct to Colistin Therapy in the Treatment of Multidrug-Resistant Acinetobacter baumannii
M Al-Shaer, LH Nazer… - Annals of …, 2014 - journals.sagepub.com
… patients who were infected with colistin-only-susceptible A … infections. In addition, there
was no statistically significant difference between colistin monotherapy and combination therapy …
was no statistically significant difference between colistin monotherapy and combination therapy …
Combination therapy for carbapenem-resistant Gram-negative bacteria
… colistin monotherapy versus combination therapy … combination therapies versus colistin
alone, aminoglycosides alone or other relevant monotherapies for CR bacteria, with treatments …
alone, aminoglycosides alone or other relevant monotherapies for CR bacteria, with treatments …
Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis
… Compared with colistin monotherapy, colistin combined therapy did not appear to provide
a better clinical cure (OR = 1.38, 95% CI 0.81–2.33). There was no significant difference in …
a better clinical cure (OR = 1.38, 95% CI 0.81–2.33). There was no significant difference in …
[HTML][HTML] Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
JA Viehman, MH Nguyen, Y Doi - Drugs, 2014 - Springer
… Efficacy data regarding colistin-containing combination therapy that are currently available
are … randomized trials comparing colistin monotherapy and colistin–carbapenem combination …
are … randomized trials comparing colistin monotherapy and colistin–carbapenem combination …